SK
Shannon T Kelley (General Counsel) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $431K of MDGL (1,077 sh × $400.00, as filed), executed Nov 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Nov 6
Filed Nov 6
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$431K1,077 sh × $400.00
Exec Nov 6
Filed Nov 6 · 4:36 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $342K
664 sh × $514.97
Exec Aug 17
Filed Aug 20 · 4:20 PM ET † MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $155K
360 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $344K
692 sh across 2 lots
Exec Jan 20
Filed Jan 20 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $164K
458 sh × $358.66
Exec Aug 18 2025
Filed Aug 18 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $139K
415 sh × $335.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET